ARCHIVES

Revlimid Plus Steroid Effective In Clinical Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 11 | November 30, 2007

Download PDF Visit The Full Archive

Related Articles

FDA Deputy Commissioner Gottlieb To Return To AEI.

December 15, 2006

Hospice Assn. Meeting Planned for April

January 24, 1986

NIH Funds 11 New Grants In Women’s Health Research.

September 29, 2000

Movement To Resolve Patient Care Reimbursement Problems Gains Momentum; NCI Report Adds Fuel

March 17, 1989

Phase II Elotuzumab Study Demonstrates 33 Months PFS

July 26, 2013

Funding Opportunities: RFAs Available: NCI Challenge For Tumor Classification

February 5, 1999